Clinical studies recruiting near Lugo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital Universitario Lucus Augusti · Spanish Oncology Genito-Urinary Group · NCT06724159 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · Hospital Universitario Lucus Augusti · Fundación GECP · NCT05398094 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
Phase N/A · Hospital Universitario Lucus Augusti · Inmunotek S.L. · NCT06782217 No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays
Phase N/A · Hospital Universitario Lucus Augusti · Instituto de Investigación Hospital Universitario La Paz · NCT05983978 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · Hospital Universitario Lucus Augusti · Fundación GECP · NCT06431633 Thoracic Tumours Register
Phase N/A · Hospital Universitario Lucus Augusti · Spanish Lung Cancer Group · NCT02941458 Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both
NA · Hospital Universitario Lucus Agustí · Fundación EPIC · NCT07190690 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer Site in Lugo, Spain · Mediar Therapeutics · NCT06967805 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NA · H. Lucus Augusti · PETHEMA Foundation · NCT04179929 A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase N/A · Hospital Lucus Augusti · Swedish Orphan Biovitrum · NCT05776472 Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Phase N/A · Hospital Universitario Lucus Augusti · Fundación Sociedad Española de Oncologia Médica · NCT03855592 Impact of IBD Activity on Frailty in Patients Over 60 Years
Phase N/A · Hospital Universitario Lucus Augusti · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT06844318 Coroflex® ISAR NEO PMCF Study
Phase N/A · Hospital Universitario Lucus Agusti · Fundación EPIC · NCT05698732 A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based
Phase 2 · Hospital Universitario Lucus Augusti · North Eastern German Society of Gynaecological Oncology · NCT05460000 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 National Database of Bone Metastases
Phase N/A · Ospedale Umberto I · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT06367491 Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NS
Phase 2 · University Hospital Lucus Augusti (HULA) · CatalYm GmbH · NCT07098988 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Hospital Lucus Augusti-Oncology ( Site 1432) · Merck Sharp & Dohme LLC · NCT06136624 Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic N
Phase 2 · University Hospital Lucus Augusti (HULA) · CatalYm GmbH · NCT07246863 Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Phase 3 · Hospital Universitario Lucus Augusti · PETHEMA Foundation · NCT07478991 Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lu
Phase 2 · Hospital Universitario Lucus Augusti · Fundación GECP · NCT07153445 Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · Research Site · AstraZeneca · NCT06750289 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Hospital Ribera Polusa · Vertex Pharmaceuticals Incorporated · NCT07204275 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Hospital Universitario Lucus Augusti · OSE Immunotherapeutics · NCT06472245 Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Phase N/A · Hospital Lucus Augusti · Grupo Español Multidisciplinar de Melanoma · NCT03605771 Luminal Breast Cancer Cryoablation
NA · Hospital Universitario Lucus Augusti · Lucía Graña López · NCT07447414 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Hospital Universitario Lucus Augusti · Daiichi Sankyo · NCT06899126 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652

Look up another city

Look up another condition